PMID: 33587816
Glutathione transferases in the bioactivation of azathioprine
Consumer-facing claims about BPC-157 efficacy in humans for tendinopathy, joint pain, gastrointestinal disorders, or neurological conditions therefore extrapolate from rat and HUVEC work and are not supported by controlled human evidence
Health Canada explicitly warns that unauthorized injectable peptides bypass safety reviews and may contain contaminants, incorrect doses, undisclosed ingredients, and high-risk components
This is its best-validated and most legitimate application, spanning bioprocessing and stem-cell research, and it is the reason the analog was engineered in the first place
For any company looking to enter the DoD market or even the wider government space, AFWERX is a great place to start searching for problem spaces where your commercial solutions can address pressing mission needs.